CytoDyn Inc.
CYDY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001175680
No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding CytoDyn Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 13 | 13 | 0 |
| Shares | 496.3K | 757.7K | +261.4K (+52.7%) |
| Value | $208.3K | $315.0K | +$106.7K (+51.2%) |
New holders (2)
Institutions that held CytoDyn Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hollencrest Capital Management | 247,000 | $103.0K | 0.01% |
| Virtue Capital Management, LLC | 45,000 | $19.0K | 0.00% |
Sold out (2)
Institutions that held CytoDyn Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Captrust Financial Advisors | 15,551 | $7.00K |
| United Community Bank | 15,000 | $6.30K |